Mmp and Impurities

NNGH is a matrix metalloproteinase 3 (MMP-3) inhibitor with anticancer activity that counteracts the inhibitory …

Prinomastat: orally active, crosses blood-brain barrier, inhibits MMP-1/2/3/9, Ki/IC50s: 0.05-0.3/5.0-79 nM, antitumor.

AGPS-IN-2i inhibits alkylglycerol phosphate synthase, affecting ether lipid metabolism and reducing cancer cell migration and …

MMP-7-IN-3 is a potent, selective MMP-7 inhibitor that effectively suppresses the progression of kidney fibrosis …

Apratastat is an orally active, potent, and reversible dual inhibitor of tumor necrosis factor-α converting …

XL-784 inhibits MMPs; IC50: 1900 nM (MMP-1), 0.81 nM (MMP-2), 120 nM (MMP-3), 10.8 nM …

TP0556351: potent MMP2 inhibitor with 0.2 nM IC50, reduces collagen in pulmonary fibrosis mice.

Ro 31-9790 is a synthetic inhibitor of metalloproteinase (MMP).

MMP13-IN-3 is an oral, selective MMP-13 inhibitor with IC50 of 1 nM, >1000x selective, for …

IK-862 is a selective TACE inhibitor with potential anti-inflammatory and anticancer activity for the study …

MMP-7-IN-2 acts as a selective and potent MMP7 inhibitor and can be used to study …

Aderamastat (FP-025) is an orally active matrix metalloproteinase 12 (MMP-12) inhibitor indicated for the study …

MMP3 inhibitor 1 is a potent and highly selective inhibitor of MMP-3 (IC50 of 1 …

PNU-248686A is an inhibitor of matrix metalloproteinase (MMP).

UK 356618 is a potent and selective inhibitor of matrix metalloprotease-3 (IC50: 5.9 nM).

UK-370106 is a potent and highly selective inhibitor of MMP-3 with IC50 of 23 nM …

SD-7300 (SC-81490) functions as an orally active inhibitor targeting MMP-2, MMP-9, and MMP-13, exhibiting potent …

CM-352 is a metalloproteinase inhibitor that reduces brain damage and improves functional recovery in rat …

RJF02215, an MMP-9 inhibitor, exhibits growth inhibitory activity against the ovarian cancer cell line SKOV3. …

BT1718 is a bicyclic peptide conjugate that targets MT1-MMP, a protease overexpressed in various advanced …